Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Damla, Uludağ"'
Autor:
Damla Uludağ, Sadık Bay, Bilgesu Onur Sucu, Özgecan Şavluğ İpek, Thomas Mohr, Mustafa Güzel, Nihal Karakaş
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Change in the energy metabolism of cancer cells, which display significant differences compared to normal cells, is a rising phenomenon in developing new therapeutic approaches against cancers. One of the metabolic enzymes, hexokinase-II (HK-II) is i
Externí odkaz:
https://doaj.org/article/2f2e98f9bf9a49a594df53503809c75d
Autor:
Nihal Karakaş, Süleyman Üçüncüoğlu, Damla Uludağ, Birnur Sinem Karaoğlan, Khalid Shah, Gürkan Öztürk
Publikováno v:
Cells, Vol 11, Iss 3, p 465 (2022)
The novel pathogenic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease 2019 (COVID-19). Mesenchymal stem cells (MSCs) are currently utilized in clinics for pulmonary inflammatory diseases, including acute respira
Externí odkaz:
https://doaj.org/article/174e434c26244d92a40a5ece1fd256a0
Autor:
Nihal KARAKAŞ, Mehmet Evren OKUR, Tuğba SAĞIR, Damla ULUDAĞ, Derya Çiçek POLAT, Ayşe Esra KARADAĞ
Publikováno v:
Ankara Universitesi Eczacilik Fakultesi Dergisi. :781-791
Objective: Vaccinium myrtillus L. fruits are consumed as food. This research was aimed to evaluate V. myrtillus methanol extract antioxidant and cytotoxic activities and determine its anti-cancer potential to further study against gastric cancer. Mat
Autor:
Damla, Uludağ, Sadık, Bay, Bilgesu Onur, Sucu, Özgecan, Şavluğ İpek, Thomas, Mohr, Mustafa, Güzel, Nihal, Karakaş
Publikováno v:
Frontiers in pharmacology. 13
Change in the energy metabolism of cancer cells, which display significant differences compared to normal cells, is a rising phenomenon in developing new therapeutic approaches against cancers. One of the metabolic enzymes, hexokinase-II (HK-II) is i
Autor:
Damla, Uludağ, Nihal, Karakaş
Publikováno v:
Anticancer research. 41(7)
Pseudomonas exotoxin (PE) is one of the most widely used toxins in the construction of therapeutic fusion proteins in pre-clinical studies followed by phase trials. In principle, PE acts by blocking protein synthesis through catalyzing the inactivati
Autor:
AKENGİN, Gültekin1 gultekinakengin@gmail.com, ERSAN, Merve1 mervesenoymak@gmail.com, ÇİÇEKLİ, Kübra1 kubracicekli@gmail.com, TUĞRUL, Damla2 tugruldamla@gmail.com
Publikováno v:
Dumlupinar University Journal of Social Science / Dumlupinar Üniversitesi Soysyal Bilimler Dergisi. Jul2018, Issue 57, p74-83. 10p.
Autor:
Uludağ, Damla, Bay, Sadık, Sucu, Bilgesu Onur, Şavluğ İpek, Özgecan, Mohr, Thomas, Güzel, Mustafa, Karakaş, Nihal
Publikováno v:
Frontiers in Pharmacology; 5/23/2022, Vol. 13, p1-11, 11p
Autor:
Karakaş, Nihal1,2 (AUTHOR) nkarakas@medipol.edu.tr, Üçüncüoğlu, Süleyman2,3 (AUTHOR) duludag@st.medipol.edu.tr, Uludağ, Damla2,4 (AUTHOR) birnur.karaoglan@std.medipol.edu.tr, Karaoğlan, Birnur Sinem2 (AUTHOR) gozturk@medipol.edu.tr, Shah, Khalid5 (AUTHOR) kshah@bwh.harvard.edu, Öztürk, Gürkan2,6 (AUTHOR)
Publikováno v:
Cells (2073-4409). Mar2022, Vol. 11 Issue 3, p465-N.PAG. 1p.